Vascular Closure Devices

Vascular Closure Devices

Reduction in Interventional Cardiology Treatment Means Patients Are Not Receiving Timely Care. Vascular Closure Devices Slumps by -3.9% On the Back of Declining Procedures

The global market for Vascular Closure Devices is projected to decline by over -3.9% in the year 2020 and thereafter recover and grow to reach US$1.1 billion by the year 2027, trailing a post COVID-19 CAGR of 6.8% over the analysis period 2020 through 2027. A vascular closure device is a medical device designed to provide rapid hemostasis and reduce vascular complications after percutaneous femoral access and. Vascular closure devices also improve patient comfort, reduce discomfort associated with prolonged bed rest, facilitate early patient mobilization, and decrease hospital length of stay. These devices have emerged as an effective alternative to traditional mechanical compression for femoral artery closure. Suture-based and metal clip-based vascular closure devices reduce time to hemostasis when compared with manual or mechanical compression. Vascular closure devices are being widely used in patients undergoing cardiac catheterization through femoral arterial access. Cardiovascular procedures that require catheterization include interventional procedures such as angioplasty, coronary thrombectomy and placement of a stent, and diagnostic procedures that help diagnose diseased blood vessels. Vascular closure devices are particularly useful for large patients not suitable for manual compression, patients on blood thinning medications such as heparin or warfarin, and sicker or geriatric patients unable to lie flat after angiographic procedure for several hours.

The market in the current year 2020 is hurting from the disruptions and excessive pressure exerted on healthcare systems by the COVID-19 pandemic. Six months into the pandemic, this unprecedented public healthcare crisis continues to evolve and shows no signs of receding. The pandemic has impacted all areas of healthcare provision, including cardiovascular (CVD) care and has necessitated the prioritization of healthcare infrastructure for COVID-19 patients, affecting other patients across the world. With all elective surgeries cancelled and postponed there has been a significant drop in angiogram diagnostic test procedures and other cardiac surgeries. Several factors have affected delivery of timely CVD care including social distancing norms; reallocation of staff in cardiology department to covid-19 care; cancelation of cardiac imaging; cancelation of elective procedures; closure of outpatient clinics; shortage of P.P.E; hospital initiated postponement of scheduled angiograms; increased fear & anxiety among patients over safety in hospital settings; delayed diagnosis of acute coronary syndrome; deterioration of cardiac health of patients; late admission of patients to hospitals with acute precipitated cardiac emergencies; overwhelmed healthcare staff & facilities. All of these factors are reducing patient throughput in cardiology centers worldwide thereby reducing demand for cardiac care equipment including vascular closure devices.

In the post COVID-19 period as the world learns to live with the virus and healthcare services resume, the market will witness a return to growth. The postponements in screenings and delays in diagnosis and treatments will create pent-up demand for cardiac care services. The year 2021 is expected to witness steady growth in CVD surgeries requiring femoral artery cardiac catheterization. Increasing burden of CVD will continue to spur growth in the market over the medium to long-term period. CVD is one of the major causes of deaths worldwide. By 2030, the number of deaths due to CVDs is forecast to reach 24 million. The significant rise in the number of cardiac interventional procedures therefore is anticipated to create strong demand growth scenario for VCDs over the coming years. Increasing use of imaging technologies for monitoring cardiac functions and radiotherapy will also create market growth opportunities as they lead to increase heart surgeries performed. With the rise in the number of interventional procedures needing larger devices, there will be increased demand for larger-bore vascular access arteriotomies. Devices utilized for endovascular aneurysm repair (EVAR), transcatheter aortic valve implantation (TAVI), balloon aortic valvuloplasty (BAV), and percutaneous ventricular assist device (VAD) implantation require larger access, making it hard to close using traditional methods. Large-bore femoral access sites have been linked with morbidity, including higher times to obtain hemostasis, longer procedure time, delayed ambulation, higher costs and complication rates. Faster hemostasis reduces bleeding complications, saves nursing time after the procedure, increases patient throughput, quickens patient ambulation, and increases overall patient satisfaction. Further, it supports hospitals following percutaneous coronary intervention (PCI) programs. In November 2018, Vivasure Medical Ltd. launched the large-bore PerQseal closure device in European region. During the same year, Cardiva Medical Inc. received premarhet approval (PMA) for Vascade MVP venous vascular closure system from the US FDA. Vascade MVP is labelled and designed to assist in multi-site venous closures for French sized 6-12 inner diameter sheaths.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Advanced Vascular Dynamics
  • Cardinal Health, Inc.
  • Cardival Medical, Inc.
  • Endocor GmbH
  • Medtronic PLC
  • Merit Medical Systems Inc.
  • Morris Innovative Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Transluminal Technologies LLC
  • Tricol Medical Inc.
  • Vivasure Medical Ltd.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Vascular Closure Devices – A Prelude
Benefits
Active Approximators
Passive Approximators
External Hemostatic Devices
Vascular Closure Devices to Witness Steady Growth Post COVID-19
Interventional Cardiology to Dominate the Market
Passive Approximators Lead the Market
Femoral Access Type Leads the Market
United States Holds a Dominant Share, Asia-Pacific to Witness Rapid Growth
Competition
Growth Restraints
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Medical Device Companies Focus on Developing Advanced Biomechanical VCDs
Increasing Demand for Large-bore Vascular Closure Devices
Select Large Bore Closure Devices
Cardiovascular Diseases: A Significant Contributor to Market Growth
EXHIBIT 1: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
EXHIBIT 2: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
Aging Population Drives Demand for Vascular Closure Devices
EXHIBIT 3: Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
Life Expectancy for Select Countries in Number of Years: 2019
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
Recent Approvals and Launches
Essential Medical Inc Receives FDA Clearance for its Large-Bore Vascular Closure Device
Vascade MVP Vascular Closure System Obtains Approval from FDA
Large Bore PerQseal Closure Device Introduced in Europe
Cordis Introduces Mynx Control Vascular Closure Device
FDA Approves Teleflex’s Vascular Closure Device
Vasorum Set to Commercialize a New Vascular Closure Device across the US
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Vascular Closure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
TABLE 4: World Current & Future Analysis for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Passive Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Passive Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 7: World Current & Future Analysis for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Active Approximators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Active Approximators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 10: World Current & Future Analysis for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for External Hemostatic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for External Hemostatic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 13: World Current & Future Analysis for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Interventional Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Interventional Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 16: World Current & Future Analysis for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Interventional Radiology/Vascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Interventional Radiology/Vascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 19: World Current & Future Analysis for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Femoral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Femoral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
TABLE 22: World Current & Future Analysis for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Radial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Radial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 25: USA Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 26: USA Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 27: USA 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
TABLE 28: USA Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 29: USA Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 30: USA 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
TABLE 31: USA Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 32: USA Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 33: USA 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
CANADA
TABLE 34: Canada Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 35: Canada Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 36: Canada 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
TABLE 37: Canada Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 38: Canada Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 39: Canada 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
TABLE 40: Canada Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 41: Canada Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 42: Canada 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
JAPAN
Graying Population Spurs Growth of Vascular Closure Devices
TABLE 24: Japanese Population by Age Group (2015 & 2040): Percentage Share Breakdown of Population for 0-14, 15-64 and 65 & Above Age Groups
TABLE 43: Japan Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 44: Japan Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 45: Japan 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
TABLE 46: Japan Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 47: Japan Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 48: Japan 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
TABLE 49: Japan Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 50: Japan Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 51: Japan 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
CHINA
TABLE 52: China Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 53: China Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 54: China 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
TABLE 55: China Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 56: China Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 57: China 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
TABLE 58: China Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 59: China Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 60: China 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
EUROPE
Ageing Demography – An Opportunity Indicator
EXHIBIT 4: European Population by Age Group (2016, 2030 & 2050): Percentage Share Breakdown by Age Group for 0-14, 15-64, and 65 & Above
TABLE 61: Europe Current & Future Analysis for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
TABLE 62: Europe Historic Review for Vascular Closure Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 63: Europe 15-Year Perspective for Vascular Closure Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
TABLE 64: Europe Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 65: Europe Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 66: Europe 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
TABLE 67: Europe Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 68: Europe Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 69: Europe 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
TABLE 70: Europe Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 71: Europe Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 72: Europe 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
FRANCE
TABLE 73: France Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 74: France Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 75: France 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
TABLE 76: France Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 77: France Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 78: France 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
TABLE 79: France Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 80: France Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 81: France 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
GERMANY
TABLE 82: Germany Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 83: Germany Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 84: Germany 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
TABLE 85: Germany Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 86: Germany Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 87: Germany 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
TABLE 88: Germany Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 89: Germany Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 90: Germany 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
ITALY
TABLE 91: Italy Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 92: Italy Historic Review for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 93: Italy 15-Year Perspective for Vascular Closure Devices by Type - Percentage Breakdown of Value Sales for Passive Approximators, Active Approximators and External Hemostatic Devices for the Years 2012, 2020 & 2027
TABLE 94: Italy Current & Future Analysis for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 95: Italy Historic Review for Vascular Closure Devices by Procedure - Interventional Cardiology and Interventional Radiology/Vascular Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 96: Italy 15-Year Perspective for Vascular Closure Devices by Procedure - Percentage Breakdown of Value Sales for Interventional Cardiology and Interventional Radiology/Vascular Surgery for the Years 2012, 2020 & 2027
TABLE 97: Italy Current & Future Analysis for Vascular Closure Devices by Access - Femoral and Radial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
TABLE 98: Italy Historic Review for Vascular Closure Devices by Access - Femoral and Radial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
TABLE 99: Italy 15-Year Perspective for Vascular Closure Devices by Access - Percentage Breakdown of Value Sales for Femoral and Radial for the Years 2012, 2020 & 2027
UNITED KINGDOM
TABLE 100: UK Current & Future Analysis for Vascular Closure Devices by Type - Passive Approximators, Active Approximators and External Hemostatic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook